Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Intercure Ltd.Bullish
InterCure has regained compliance with the Nasdaq minimum bid price requirement, effectively resolving the previously received delisting notice. Following a period where its share price remained at or above $1.00 for 10 consecutive business days from August 24 to September 4, 2026, Nasdaq confirmed the matter is now closed.…more
Intercure Ltd.
InterCure Ltd. completed a private placement of 1,579,028 units between August 12 and August 25, 2026, raising gross proceeds of $5.3 million. Each unit consists of one ordinary share and one warrant, priced at $4.71 per unit with a warrant exercise price of $7.07. The proceeds will be used for working capital and the rehabilitation of the Nir Oz facility of its subsidiary, Canndoc Ltd.…more
Intercure Ltd.
Intercure Ltd. completed a private placement of 1,579,028 units on August 25, 2026, raising gross proceeds of $5 million. Each unit consists of one ordinary share and one warrant exercisable at $1.59 for five years, with proceeds intended for working capital and the rehabilitation of the Nir Oz facility. The participation of CEO Alexander Rabinovich, totaling approximately $2 million, remains subject to shareholder approval, while the participation of other investors has already been finalized.…more
9 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
InterCure Regains Nasdaq Compliance
InterCure has regained compliance with Nasdaq's minimum bid price requirement, successfully avoiding potential delisting. The company confirmed it now meets all necessary listing standards to remain on the Nasdaq Global Market.…more
●●●●●●●● ●●●●● ●●●●●●
InterCure has finalized a settlement with Israeli tax authorities and a compensation fund regarding approximately $77 million in indirect war damages. This agreement resolves financial uncertainties related to the conflict and secures compensation for the company.…more
●●●●●●●● ●●●●● ●●●●●●
InterCure has reached a final settlement of 230 million NIS (approximately $77 million) with Israeli authorities for indirect damages caused by the war. The company plans to use these funds to accelerate the rehabilitation of its Nir Oz facility and expand its presence in the German medical cannabis market.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.